3-甲基丁-1,3-二烯-2-基乙酸酯 | 16824-14-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 3-甲基丁-1,3-二烯-2-基乙酸酯
• 英文名称: acetic acid-(2-methyl-1-methylen-allyl ester)
• 英文别名: Essigsaeure-(2-methyl-1-methylen-allylester)；3-methylbuta-1,3-dien-2-yl acetate
• CAS: 16824-14-9
• 化学式: C₇H₁₀O₂
• 分子量: 126.155
• InChiKey: IPFWQVCMDDZCMA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-甲基-1-丁烯-3-酮 、 乙烯酮 在 硫酸 作用下， 生成 3-甲基丁-1,3-二烯-2-基乙酸酯
  参考文献：
  名称：

  Hagemeyer, Industrial and Engineering Chemistry, 1949, vol. 41, p. 769

  摘要：

  DOI：

文献信息

• Graft copolymer and process for producing the same
  申请人：IDEMITSU KOSAN COMPANY LIMITED

  公开号：EP0490269A1

  公开（公告）日：1992-06-17

  There is provided a process for producing a styrenic graft copolymer which comprises coplymerizing a styrenic monomer and a styrenic monomer having a hydrocarbon radical with an unsaturated bond in the presence of a catalyst comprising as primary ingredient (A) a transition metal compound and (B) a contact product of an organoaluminum compound and a condensation agent or (C) a compound which produces an ionic complex by reacting with the above-mentioned transition metal compound and subsequently graft polymerizing an ethylenically unsaturated monomer onto the resultant styrenic copolymer. The above-described styrenic graft copolymer is greatly improved in terms of compatibility, adhesivity, coatability and wettability while preserving heat resistance and chemical resistance thereof, and thus effective as a variety of constructional materials and compatibilizing agents. Furthermore, the composition or multi-layer material comprising the above-mentioned styrenic graft copolymer is widely utilized in a variety of application field including film, sheet, especially stampable sheet, container, packaging material, automobile parts, electrical and electronic parts, etc.

  提供了一种生产苯乙烯接枝共聚物的工艺，该工艺包括在催化剂存在下，使苯乙烯单体和具有不饱和键烃基的苯乙烯单体共聚，催化剂的主要成分包括(A)过渡金属化合物和(B)有机铝化合物与缩合剂的接触产物或(C)通过与上述过渡金属化合物反应产生离子络合物的化合物，然后将乙烯基不饱和单体接枝聚合到生成的苯乙烯共聚物上。上述过渡金属化合物反应生成离子络合物的化合物，然后将乙烯不饱和单体接枝聚合到生成的苯乙烯共聚物上。 上述苯乙烯接枝共聚物在保持其耐热性和耐化学性的同时，在相容性、粘合性、涂覆性和润湿性方面得到了极大的改善，因此可以有效地用作各种建筑材料和相容剂。此外，由上述苯乙烯接枝共聚物组成的组合物或多层材料可广泛应用于各种应用领域，包括薄膜、片材，尤其是可冲压片材、容器、包装材料、汽车零件、电子电气零件等。
• Surface-modified molded product of synthetic resin and process for producing it
  申请人：Mitsubishi Chemical Corporation

  公开号：EP0585662A1

  公开（公告）日：1994-03-09

  A process for producing a surface-modified molded product of synthetic resin, which comprises contacting a fluorine-containing gas to the surface of a molded product of synthetic resin and then contacting a polymerizable monomer to form a new polymer layer on the surface of the molded product.

  一种生产合成树脂表面改性模塑产品的工艺，包括在合成树脂模塑产品表面接触含氟气体，然后接触可聚合单体，在模塑产品表面形成新的聚合物层。
• Organometallic compounds and polymers made therefrom
  申请人：ELF ATOCHEM NORTH AMERICA, INC.

  公开号：EP0723967A1

  公开（公告）日：1996-07-31

  Compounds of formula (I) are disclosed: wherein L1 is a main group atom, L2 is a neutral ligand, M is a transition element or a metal element of Group 13, 14, 15, or 16 of the Periodic Table, x is the number of coordination sites of M, R1 is a polymerizable group, R2, R3, and R4 are ligands, and R5 is an anionic ligand. The compounds or monomers of formula (I) are capable of conversion to polymers by combination with one or more other known monomers, such as methyl methacrylate. Such polymers can then be added as a binder in a paint formulation to make marine antifouling coating compositions. Also described is a method to prevent fouling on surfaces wherein a composition containing a metal complex compound of formula (II): wherein M, x, L2, n, and R4 have the same meaning as in formula (I), is applied to the surface susceptible to fouling.

  公开了式 (I) 化合物： 其中 L1 是主基团原子，L2 是中性配位体，M 是过渡元素或元素周期表第 13、14、15 或 16 族金属元素，x 是 M 的配位位点数，R1 是可聚合基团，R2、R3 和 R4 是配位体，R5 是阴离子配位体。式 (I) 的化合物或单体可与一种或多种其他已知单体（如甲基丙烯酸甲酯）结合转化为聚合物。这种聚合物可作为粘合剂加入涂料配方中，制成船舶防污涂料组合物。此外，还介绍了一种防止表面结垢的方法，其中的组合物含有式 (II) 的金属络合物： 其中 M、x、L2、n 和 R4 的含义与式（I）中的含义相同。
• Process for producing a hydrogenated polymer
  申请人：Kuraray Co., Ltd.

  公开号：EP1241189A1

  公开（公告）日：2002-09-18

  The present invention provides an industrially advantageous process for producing a hydrogenated polymer comprising subjecting a polymer having an olefinic carbon-carbon double bond and hydroxy group and/or a functional group which is convertible into hydroxy group or convertible into hydroxymethyl group to hydrogenation under the presence of palladium on a basic activated carbon and/or platinum on a basic activated carbon. The process of the present invention can produce a hydrogenated polymer having hydroxy group and/or a functional group which is convertible into hydroxy group or convertible into hydroxymethyl group with high retention of a functional group and can achieve a high hydrogenation ratio together with good hydrogenation rate.

  本发明提供了一种生产氢化聚合物的具有工业优势的工艺，该工艺包括在碱性活性炭上的钯和/或碱性活性炭上的铂存在下，使具有烯烃碳碳双键和羟基和/或可转化为羟基或可转化为羟甲基的官能团的聚合物进行氢化。本发明的工艺可以生产出具有羟基和/或可转化为羟基或可转化为羟甲基的官能团的氢化聚合物，且官能团保留率高，氢化率高，氢化速率好。
• Responsive microgel and methods related thereto
  申请人：——

  公开号：US20030152623A1

  公开（公告）日：2003-08-14

  A responsive microgel is provided which responds volumetrically and reversibly to a change in one or more aqueous conditions selected from the group consisting of (temperature, pH, and ionic conditions) comprised of an ionizable network of covalently cross-linked homopolymeric ionizable monomers wherein the ionizable network is covalently attached to an amphiphilic copolymer to form a plurality of ‘dangling chains’ and wherein the ‘dangling chains’ of amphiphilic copolymer form immobile micelle-like aggregates in aqueous solution. A responsive microgel is further provided that comprises at least one therapeutic entity and delivers a substantially linear and sustained release of the therapeutic entity under physiological conditions.

  本发明提供了一种响应型微凝胶，该微凝胶可对选自由温度、pH 值和离子条件组成的组中的一种或多种水性条件的变化作出体积上和可逆的响应、和离子条件）组成的共价交联均聚可离子化单体的可离子化网络，其中可离子化网络与两性共聚物共价连接，形成多条 "悬链"，两性共聚物的 "悬链 "在水溶液中形成不动的胶束状聚集体。还提供了一种响应性微凝胶，它包含至少一种治疗实体，并能在生理条件下提供治疗实体的线性和持续释放。